Cambodia vs Portugal: HIV/AIDS deaths averted by antiretroviral therapy
Cambodia
1,355 deaths
in 2024
Portugal
1,420 deaths
in 2024
Cambodia rank
68th
Portugal rank
66th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cambodia
- Portugal
How they compare
Portugal currently reports 1,420 deaths against 1,355 deaths in Cambodia, a difference of 65 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Portugal ahead.
Cambodia ranks 68th and Portugal ranks 66th of 157 countries.
Across the 4 decades both report, Cambodia averaged higher in 3 and Portugal in 1.
Head to head by decade
| Decade | Cambodia | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 125.06 deaths | 125.06 deaths | Portugal |
| 2000s | 1,701 deaths | 1,361 deaths | 340.07 deaths | Cambodia |
| 2010s | 3,140 deaths | 1,650 deaths | 1,490 deaths | Cambodia |
| 2020s | 1,580 deaths | 1,458 deaths | 121.9 deaths | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cambodia or Portugal?
- Portugal, at 1,420 deaths against 1,355 deaths in Cambodia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cambodia and Portugal?
- 65 deaths, with Portugal ahead.
- How many years of comparable data are there for Cambodia and Portugal?
- 35 years are reported by both, from 1990 to 2024.
- How do Cambodia and Portugal rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cambodia ranks 68th and Portugal ranks 66th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.